Skip to main content

Accuracy of urine flow cytometry and urine test strip in predicting relevant bacteriuria in different patient populations

Abstract

Background

Urinary tract infection (UTI) is diagnosed combining urinary symptoms with demonstration of urine culture growth above a given threshold. Our aim was to compare the diagnostic accuracy of Urine Flow Cytometry (UFC) with urine test strip in predicting bacterial growth and in identifying contaminated urine samples, and to derive an algorithm to identify relevant bacterial growth for clinical use.

Methods

Species identification and colony-forming unit (CFU/ml) quantification from bacterial cultures were matched to corresponding cellular (leucocytes/epithelial cells) and bacteria counts per μl. Results comprise samples analysed between 2013 and 2015 for which urine culture (reference standard) and UFC and urine test strip data (index tests, Sysmex UX-2000) were available.

Results

47,572 urine samples of 26,256 patients were analysed. Bacteria counts used to predict bacterial growth of ≥105 CFU/ml showed an accuracy with an area under the receiver operating characteristic curve of > 93% compared to 82% using leukocyte counts. The relevant bacteriuria rule-out cut-off of 50 bacteria/μl reached a negative predictive value of 98, 91 and 89% and the rule-in cut-off of 250 bacteria/μl identified relevant bacteriuria with an overall positive predictive value of 67, 72 and 73% for microbiologically defined bacteriuria thresholds of 105, 104 or 103 CFU/ml, respectively. Measured epithelial cell counts by UFC could not identify contaminated urine.

Conclusions

Prediction of a relevant bacterial growth by bacteria counts was most accurate and was a better predictor than leucocyte counts independently of the source of the urine and the medical specialty ordering the test (medical, surgical or others).

Peer Review reports

Background

Urinary tract infections (UTI) are among the most common infections, both in the outpatient [1] and hospital setting [2]. They directly prolong hospital stays [3], contribute considerably to health care costs [4], increase antibiotic use, thus contributing to high levels of antibiotic resistances in uro-pathogens [5], and ultimately increase mortality [6].

The generally accepted definition of UTI includes both compatible symptoms and the presence of bacteria in urine (bacteriuria) [7]. The amount of bacteria that defines a” relevant bacterial growth” from urine culture is typically 105 or more colony forming units (CFU) per ml of up to two bacterial species, although lower thresholds exist in particular for vulnerable patients or sterile sampling conditions [7, 8]. As clinical symptoms have low sensitivity and specificity, the reference method, urine culture, is necessary for a definite diagnosis of bacteriuria. However, this usually takes more than 24 h.

Rapidly available urine tests that measure surrogates of infection on test strips or count microorganisms (as in urine flow cytometry [UFC]) are utilized to anticipate the pending microbiological test result to support the diagnosis of UTI, and to guide the decision on whether to start antibiotic treatment or not.

However, their interpretation is controversial with many studies reporting different predictive values that depend on the patient collective and the defined threshold for positivity of urine cultures [9, 10].

The aim of the present study was to compare the diagnostic accuracy of UFC to urine test strip in predicting relevant bacterial growth in urine culture, and to provide easy to apply interpretation guidance based on different thresholds and patients populations.

Methods

Setting and study population

This retrospective study includes all specimens submitted for urine culture from January 2013 to December 2015 to the Division of Clinical Bacteriology and Mycology of the University Hospital Basel, Switzerland, a 855-bed tertiary care center with approximately 35,000 admissions per year and different outpatient departments. Outpatient departments include a general internal medicine walk-in-clinic, a family medicine clinic and specialist clinics. The study also includes all submitted samples from paediatric patients of the University Children’s Hospital Basel.

Most urine specimens submitted for culture are routinely analysed by test strip and UFC in the same ISO/IEC 17025 accredited laboratory facilities. We included all urine samples for which complete results from UFC, test strip and urine cultures were available.

Ethics statement

Data access, processing and analysis for this study were approved by the local ethics committee (Ethikkommission Nordwest- und Zentralschweiz, Switzerland, EKNZ Nr. 2016–01534) at the request of the authors. The need of a patient informed consent was waived by the ethics committee in accordance with Swiss law because the study included only anonymised laboratory test results.

Sample collection and preparation

Urine was collected in sterile containers that were submitted to the laboratories usually within two hours. According to local standard of practice, each urine sample was divided right after collection into two vials, one for bacterial culture (stabilized with boric acid, Urine-Monovette, Sarstedt) and the other for test strip and flow cytometry analysis (without stabilizers, Urine-Monovette, Sarstedt). Clean voided midstream urine was the preferred mode of urine collection (without prior peri-urethral cleaning). Sample collection and preparation was similar for all departments (including outpatients).

Test strip and flow cytometry

Both UFC and test strip were automatically analysed by UX-2000 (Sysmex, Kobe, Japan) flow cytometry instruments. Test strip parameters were measured with the dual-wavelength reflectance method applied to test strips (Meditape® II 9 U, Sysmex, Kobe, Japan). The parameters included in this analysis are: nitrite, leucocyte-esterase activity (semiquantitative: positive test results above 25 leukocytes/μl) and hemoglobin/myoglobin (peroxidase-based reaction that is interpreted as positive at values above 0.03 mg/dl, precision according to manufacturer specifications).

Cellular (leukocytes/erythrocytes) and bacteria counts per μl urine were obtained from the flow cytometer unit of the UX-2000 (identical to the previous model, the UX-1000i). The UX-2000 consecutively identifies and counts leukocytes, erythrocytes (both with a linear range of 1–5000 /μl with +/− 10% precision) and epithelial cells (a sum of squamous and small round cell counts, 1–200 /μl linear range with +/− 30% precision) in the fluorescent polymethine dyed urine (the dye binds to DNA). Bacteria are quantified using the same dye but in a separate process (5–10′000 /μl linear range with +/− 20% precision). The analysis ranges of flow cytometry and test strip indicated are those supplied by the manufacturer.

UFC was performed as soon as samples were available in the laboratory and results were automatically reported in the laboratory information system.

Bacterial cultures for quantification and species identification

Microbiological growth was assessed by inoculation of blood-agar and non-selective CHROMagar plates (bioMérieux, Lyon, France) with 1 μl urine stabilized by boric acid. Inoculation was performed in batches thrice during business hours. Both plates were usually quantified twice at 24 h and 48 h of aerobic incubation at 37 °C. Bacterial quantification was performed by experienced and trained technicians. Their judgment was based on accredited standard operating procedures to account for reproducibility. Representative colonies of dominant bacteria were identified on a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer (Bruker Biotyper, Germany) or using biochemical profiling on a Vitek 2 system (bioMérieux SA, Lyon, France).

“Relevant bacteriuria/bacterial growth” was defined, in accordance with the UTI definition of the Centers for Disease Control and Prevention, as urine containing no more than two identified species of which at least one is detected in an amount of 105 CFU/ml or more [7]. Lower thresholds of relevant bacteriuria (i.e. 104 and 103) were used to calculate test performances when indicated. Samples were defined as contaminated when microbiological cultures yielded polymicrobial growth without a dominant species.

Data analysis and algorithm derivation

The diagnostic accuracy and predictive values of UFC and urine test strip were compared with the reference standard of bacterial culture. Combinations of tests with discrete results were linked by Boolean operators to test improvements in accuracy performances. Sensitivity, specificity, positive and negative predictive values were calculated for representative cut-offs (selected based on previously published data for comparison and around optimal cut-offs from receiver operator characteristic (ROC) curves). ROC curves and their respective areas under the curves (AUC) were calculated in R 3.3.0 [11] using the pROC package [12] to determine discriminative power and optimal, unweighted cut-offs. Analyses were stratified according to sex and hospital divisions. Calculated optimal cut-offs from ROC curves were used to derive a diagnostic algorithm to predict relevant bacteriuria. To estimate the robustness of the developed algorithm, the diagnostic accuracy of the selected cut-offs were calculated in a repeated 10-fold-split (of equal size) cross validation approach of the whole dataset using the caret package [13], with 10 independent repetitions.

Results

Test results of 47,572 urine samples from 26,256 individual patients were analysed, representing 72% of all urine cultures performed during the study period. A total of 18,403 available microbiological results were excluded from the analysis as respective results of UFC and/or urine test strip were missing (Supplementary Fig. S1).

The samples and respective patient characteristics are summarized in Table 1. A quarter of all analyses revealed relevant bacteriuria (≥105 CFU/ml) (Supplementary Table S1). Samples of male patients had higher leukocyte but lower bacteria counts than samples of female patients (Supplementary Fig. S2 and Supplementary Table S2).

Table 1 Patient characteristics and sample information available for the analysed samples

Escherichia coli was the most frequently identified microorganism, followed by Klebsiella spp., Lactobacillus spp. and Enterococcus faecalis (Supplementary Table S3).

Predictive values of UFC and test strips were calculated for all samples and different microbiological thresholds of relevant bacteriuria (Table 2), and individually for both sexes and across all different medical specialties and ordering institutions respectively (Supplementary Table S4). Bacteria counts measured by urine flow cytometry showed the best discriminatory power to identify relevant bacteriuria. Only the detection of nitrate proved to be unmatched in its specificity (98%), however, revealed a poor sensitivity of below 40%. Leukocyte counts using a cut-off of about 30–40 leukocytes reached predictive values comparable to leukocyte esterase detection on test strips. Comparison of relevant microbial growth between different species revealed an overall higher sensitivity of bacteria counts in detecting gram-positive species where test strips performed poorly (Supplementary Table S5).

Table 2 Sensitivity (SENS), specificity (SPEC), positive and negative predictive values (PPV and NPV), and numbers of false negative (FN) and false positive results (FP) when test strips or flow cytometry was used to separate relevant bacteriuria from bacteriuria, contamination or no culture growth of all samples using different cut-off values. Test performances for different definitions of relevant bacteriuria (≥ 105, ≥ 104 and ≥ 103, respectively) are listed. Pos.: positive test strip result

Measures of discrimination were visualized by ROC curves for bacteria count and leukocyte count as predictors of positive urine culture (Fig. 1). Lowering the threshold for the definition of a relevant bacteriuria to 104 or 103 CFU/ml resulted in lower optimal unweighted cut-offs in a non-linear progression for bacteria counts, while leukocyte counts did not show similar dynamics. The bacteria count ROC curves progressions were very similar (AUC between 93 and 95%) for all but the gynaecology & obstetrics division (AUC: 86.4%, Supplementary Fig. S3); ROC curves of leukocyte count test progressions resulted in wider dynamics (AUC between 74.0 and 83.6%).

Fig. 1
figure1

Receiver operating characteristic (ROC) curves of bacteria (black) and leukocyte counts (blue, triangles) with the respective optimal calculated, unweighted cut-offs (and the respective specificity/sensitivity in brackets) for 103 CFU/ml (dotted lines), 104 CFU/ml (dashed lines) and 105 CFU/ml (solid lines) and corresponding areas under the ROC curves (AUC) indicated in the table including confidence intervals (CI). Note that 103 CFU/ml and 104 CFU/ml ROC curves of leukocyte counts overlap with almost identical progression

Whole epithelial cell count (as determined by UFC) appeared to be a poor predictor of contaminated samples with a optimal cut-off value reaching a sensitivity of around 60% and a specificity of 50%, regardless of whether contaminations included all polymicrobial samples or additionally all samples with bacterial growth below 105 CFU/ml (Supplementary Fig. S4 and Supplementary Table S6).

We developed an algorithm based on bacteria count (Fig. 2). To rule out relevant bacteriuria, a cut-off of 50 bacteria/μl was selected based on the sensitivity and the negative predictive value of > 95%. To rule in relevant bacteriuria, a cut-off of 250 bacteria/μl was chosen to improve specificity across a variety of patient characteristics. The performance of the algorithm when applied to the whole data set and all subgroups is summarized in Table 3. The selected cut-offs demonstrated minor variations (mostly around or below 1% change from the median) of the predictive values in a cross validation approach (Supplementary Fig. S5 and Supplementary Table S7).

Fig. 2
figure2

Theoretical performance of the developed bacteriuria algorithm on the whole data set. Relevant bacteriuria: samples of 1–2 identified bacteria of ≥105 colony-forming unit/ml, NPV: negative predictive value, PPV: positive predictive value

Table 3 Performance of the developed algorithm to detect relevant bacteriuria (≥ 105 colony-forming units/ml) for all samples, samples of male and female patients and for samples of different divisions, respectively

Discussion

UTI is a clinical diagnosis confirmed by the detection of relevant bacterial growth in urine culture. In this context, the finding that the growth of bacteria (by microbiological culture) can be predicted by counting them seems trivially intuitive and has been confirmed by many studies for more than one decade [10, 14]. Our data reproduce these findings and extend them to a more generalisable conclusion due to the large sample size deriving from a diverse patient population, as well as head-to-head comparisons with other same-day tests.

In our experience, for diagnosis of UTI, clinicians seem to rely more on clinical symptoms considered to be “typical”, but which are poorly predictive of UTI (such as costo-vertebral angle tenderness) [15] and on dipstick test results with poor positive predictive value (e.g. leucocytes esterase) [9], rather than on results of UFC. This is possibly due to uncertainty associated with the interpretation of UFC results. We therefore focused on the clinical applicability of our results to predict bacteriuria as opposed to most studies on UFC, which are centered on the laboratory efficacy and efficiency by reducing bacterial culture and pre-selection of samples. To the best of our knowledge, this study represents the largest published dataset applied to compare the diagnostic accuracy of UFC with urine test strip for prediction of bacterial growth in urine culture in both hospital and community settings.

Calculated predictive values were very similar for bacteria counts in all subgroups except the gynaecology & obstetrics division. The dominance of samples from female patients in this division can partly explain the deviation since separate analysis of samples from all female patients across subgroups (Supplementary Fig. S6) showed a similar ROC curve progression. Additionally, a different pre-test probability is likely to influence the performance of samples from this particular division. In our study, samples from male patients had higher leukocyte counts but lower bacteria counts than from female patients. This observation was previously made and might be explained by physiological differences [16, 17].

Our analysis includes unselected samples but, due to the study design, lacks any patient-specific clinical information or information on antibiotic therapies; study results consequently only apply to the diagnosis of bacteriuria and not the clinical diagnosis of UTI. The diagnostic performance, however, is similar to a recent smaller study that included clinical symptoms and focused on sensitivity at a 104 bacteria/μl threshold (Fig. 1) [18]. An installed antibiotic therapy before sample taking might have decreased overall specificity of both, bacteria counts (counting of non-viable bacteria) as well as leucocyte counts (counting of leucocytes that persisted in the urinary tract even after bacteria have been eradicated, i.e. no bacterial growth on culture media). Since urine analysis is usually not recommended after the initiation of therapy and unidirectionally influences every test, we expect this lack of information not to limit the generalisable of our test comparison.

Approximately 28% of available microbiologically analysed urine samples were excluded since they lacked a corresponding UFC and/or test strip result. They consisted partly of urine from external sources or did not have the quantity required to perform both tests. We cannot exclude a possible bias based on this pre-selection.

We did not find a combination of two different diagnostic tests that improved the predictive values significantly (exemplified with leukocyte esterase and nitrate in Supplementary Table S4). This is not unexpected given the fact that those tests are conditionally dependent on the presence of bacteria and infection [19]. The combination of leukocyte esterase and nitrate only improved sensitivity if test performance was analysed on a species level (Supplementary Table S5). Other more complex combinations of more than two tests, in particular when the continuity of UFC variables is utilized in contrast to fixed cut-off values, might lead to improved optima of predictive values but would be more challenging to clinically interpret if not automatically integrated in the laboratory reporting system.

We did not use the bacterial morphology software that tries to distinguish gram-positive from mixed (gram-positive/gram-negative) bacteria since our initial analysis seemed to confirm insufficient performance as described earlier [20]. Similarly, erythrocytes measured by flow cytometry were neglected in our analysis since they might support primarily other urological disease diagnoses and seemed only of inferior importance for UTI, although we recognize that hematuria might be used as a sign for UTI as well.

In the context of urinary tract infection, squamous epithelial cells determined by microscopy are traditionally used to identify contaminated samples. The evidence supporting this correlation is very scarce [21] but even if valid, “epithelial cell count” from flow cytometry seems not to be a helpful parameter. According to the user manual (Sysmex flow cytometer UX-2000), depending on the setup of the instrument, the “epithelial cell count” does not include only squamous epithelial cells but is a group parameter for squamous and non-squamous epithelial cells and small round cells [22]. Small round cells “[...] include renal tubular epithelial cells, squamous epithelial cells, middle and deep layer of transitional epithelial cells [...]” [22]. In our study, the epithelial cell count by UFC was not useful to predict urine contamination and performed only slightly better than chance in this binary decision.

The calculated cut-offs seem suitable for our setting, are independent of the clinical department and robust after internal validation. Despite similar cut-offs from other studies (using identical flow cytometers) external validation is needed in order to generalise our results as are modifications of the cut-offs when instrument development progresses.

The diagnostic algorithm developed as a prediction tool for relevant bacterial growth contains two distinctive cut-offs, one optimized for sensitivity and the other for specificity, which resulted in less dependency on patient characteristics. Under the assumption of a stable, uncritical patient, a urine sample of the “undecided” group might direct the clinician to wait for bacterial culture confirmation before initiating an empiric therapy. On the other hand, the rule-in cut-off might be enough to initiate a therapy if symptoms are present.

This algorithm might help clinicians to estimate the microbiological culture result with high sensitivity and robustness and acceptable specificity and therefore improve adequate antibiotic use. Ultimately, the prognostic performance of the presented algorithm can only be evaluated by a prospective study that includes clinical parameters and allows to distinguish UTI rather than bacteriuria and to estimate the influence of the diagnostic test on therapies and other health-related outcomes.

: Conclusions

The present study showed that bacteria counts measured by UFC offer a better diagnostic accuracy for the prediction of bacterial growth in urine cultures than leukocyte count or nitrate and leukocyte esterease on test strips. Our results were used to derive a simple algorithm for clinical practice based on bacteria count alone. Epithelial cells measured by UFC did not contribute to identifying contaminated urine samples.

Availability of data and materials

Data sharing was not approved by the local ethics committee as the large datasets analysed during the current study could potentially be used for individual identification albeit being anonymised.

Abbreviations

UTI:

Urinary tract infection

CFU:

Colony-forming unit

UFC:

Urine Flow Cytometry

ROC:

Receiver operator characteristic (curve)

AUC:

Area under the (ROC) curve

References

  1. 1.

    Centers for Disease Control and Prevention. 2015 The National Ambulatory Medical Care Survey (NAMCS) summary. [https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2015_namcs_web_tables.pdf].

  2. 2.

    Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29(1):73–9.

    Article  Google Scholar 

  3. 3.

    Green MS, Rubinstein E, Amit P. Estimating the effects of nosocomial infections on the length of hospitalization. J Infect Dis. 1982;145(5):667–72.

    CAS  Article  Google Scholar 

  4. 4.

    Wilke T, Bottger B, Berg B, Groth A, Botteman M, Yu S, et al. Healthcare burden and costs associated with urinary tract infections in type 2 diabetes mellitus patients: an analysis based on a large sample of 456,586 German patients. Nephron. 2016;132(3):215–26.

    CAS  Article  Google Scholar 

  5. 5.

    Cek M, Tandogdu Z, Wagenlehner F, Tenke P, Naber K, Bjerklund-Johansen TE. Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: results from the GPIU studies 2003-2010. World J Urol. 2014;32(6):1587–94.

    Article  Google Scholar 

  6. 6.

    Li F, Song M, Xu L, Deng B, Zhu S, Li X. Risk factors for catheter-associated urinary tract infection among hospitalized patients: a systematic review and meta-analysis of observational studies. J Adv Nurs. 2018.

  7. 7.

    Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32. Most current revision available at https://www.cdc.gov/nhsn/pdfs/pscmanual/7psccauticurrent.pdf. Accessed on December 2018.

  8. 8.

    Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, et al. A guide to utilization of the microbiology Laboratory for Diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1–e94.

    Article  Google Scholar 

  9. 9.

    Deville WL, Yzermans JC, van Duijn NP, Bezemer PD, van der Windt DA, Bouter LM. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy BMC Urol. 2004;4:4.

    Article  Google Scholar 

  10. 10.

    Mejuto P, Luengo M, Diaz-Gigante J. Automated flow Cytometry: an alternative to urine culture in a routine clinical microbiology laboratory? Int J Microbiol. 2017;2017:8532736.

    Article  Google Scholar 

  11. 11.

    R Core Team. R: A Language and Environment for Statistical Computing, 2018. Available from https://www.R-project.org/. Accessed on August 2019.

  12. 12.

    Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.

    Article  Google Scholar 

  13. 13.

    Kuhn M. Caret: Classification and Regression Training. [https://CRAN.R-project.org/package=caret].

  14. 14.

    Shang YJ, Wang QQ, Zhang JR, Xu YL, Zhang WW, Chen Y, et al. Systematic review and meta-analysis of flow cytometry in urinary tract infection screening. Clin Chim Acta. 2013;424:90–5.

    CAS  Article  Google Scholar 

  15. 15.

    McIsaac WJ, Hunchak CL. Overestimation error and unnecessary antibiotic prescriptions for acute cystitis in adult women. Med Decis Mak. 2011;31(3):405–11.

    Article  Google Scholar 

  16. 16.

    Jolkkonen S, Paattiniemi EL, Karpanoja P, Sarkkinen H. Screening of urine samples by flow cytometry reduces the need for culture. J Clin Microbiol. 2010;48(9):3117–21.

    Article  Google Scholar 

  17. 17.

    Boonen KJ, Koldewijn EL, Arents NL, Raaymakers PA, Scharnhorst V. Urine flow cytometry as a primary screening method to exclude urinary tract infections. World J Urol. 2013;31(3):547–51.

    CAS  Article  Google Scholar 

  18. 18.

    Schuh SK, Seidenberg R, Arampatzis S, Leichtle AB, Hautz WE, Exadaktylos AK, et al. Diagnosis of urinary tract infections by urine flow Cytometry: adjusted cut-off values in different clinical presentations. Dis Markers. 2019;2019:5853486.

    Article  Google Scholar 

  19. 19.

    Marshall RJ. The predictive value of simple rules for combining two diagnostic tests. Biometrics. 1989;45(4):1213–22.

    Article  Google Scholar 

  20. 20.

    Geerts N, Jansz AR, Boonen KJ, Wijn RP, Koldewijn EL, Boer AK, et al. Urine flow cytometry can rule out urinary tract infection, but cannot identify bacterial morphologies correctly. Clin Chim Acta. 2015;448:86–90.

    CAS  Article  Google Scholar 

  21. 21.

    Mohr NM, Harland KK, Crabb V, Mutnick R, Baumgartner D, Spinosi S, et al. Urinary squamous epithelial cells do not accurately predict urine culture contamination, but may predict urinalysis performance in predicting Bacteriuria. Acad Emerg Med. 2016;23(3):323–30.

    Article  Google Scholar 

  22. 22.

    Sysmex (Kobe Japan). UX-2000 user manual. Updated March 2014.

Download references

Acknowledgements

Data from this study has been presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria 2017 (22. April 2017, P0338).

Authors’ information (optional)

Not applicable

Funding

This research project did not receive specific funding.

Author information

Affiliations

Authors

Contributions

CG conceptualised the study, aggregated and analysed the data, validated the results and visualised and described the findings in the original draft and following manuscript reviews. AR conceptualised the study, supplied data and interpretation and supervised the analysis. KR Supervised the analysis and edited reviews of the manuscript. STS conceptualised the study and supported the investigation, data analysis, cross validation and review/editing of the manuscript. SB supervised the study, supplied infrastructure and interpretation guidelines, lead the data analysis and was writing and reviewing the manuscript. AE initiated and conceptualised the study, supplied resources, supervised the analysis, writing and editing the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Adrian Egli.

Ethics declarations

Ethics approval and consent to participate

Data access, processing and analysis for this study were approved by the local ethics committee (Ethikkommission Nordwest- und Zentralschweiz, Switzerland, EKNZ Nr. 2016–01534) at the request of the authors. The need of a patient informed consent was waived by the ethics committee in accordance with Swiss law because the study included only anonymised laboratory test results.

Consent for publication

Not applicable.

Competing interests

The authors report no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gehringer, C., Regeniter, A., Rentsch, K. et al. Accuracy of urine flow cytometry and urine test strip in predicting relevant bacteriuria in different patient populations. BMC Infect Dis 21, 209 (2021). https://doi.org/10.1186/s12879-021-05893-3

Download citation

Keywords

  • Urinary tract infection
  • Diagnosis
  • Flow Cytometry
  • Urinalysis
  • Bacteria count
  • Urine test strip
\